{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "69842-715",
      "generic_name": "Oxymetazoline Hydrochloride",
      "labeler_name": "CVS PHARMACY, INC.",
      "brand_name": "CVS Health Sinus",
      "brand_name_suffix": "Sinus",
      "active_ingredients": [
        {
          "name": "OXYMETAZOLINE HYDROCHLORIDE",
          "strength": ".05 g/100mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "69842-715-15",
          "description": "1 BOTTLE, SPRAY in 1 CARTON (69842-715-15)  / 15 mL in 1 BOTTLE, SPRAY",
          "marketing_start_date": "20190312",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "CVS PHARMACY, INC."
        ],
        "rxcui": [
          "1000990"
        ],
        "spl_set_id": [
          "c7840511-3a4f-4547-ae90-19b085a5874e"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0050428610862"
        ],
        "unii": [
          "K89MJ0S5VY"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "SPRAY",
      "spl_id": "19d8357b-8b21-40d0-8b02-0fca7b4a9c2f",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "NASAL"
      ],
      "marketing_start_date": "20190312",
      "product_id": "69842-715_19d8357b-8b21-40d0-8b02-0fca7b4a9c2f",
      "application_number": "M012",
      "brand_name_base": "CVS Health",
      "pharm_class": [
        "Imidazolines [CS]",
        "Increased Sympathetic Activity [PE]",
        "Vasoconstriction [PE]",
        "Vasoconstrictor [EPC]"
      ]
    }
  ]
}